Third Anniversay May 12, 2006 – Columbia MD – A Global Healthcare Public Foundation announces its third Anniversary Event in collaboration with Jazz for Peace.   AIDS was unfathomable in 1981 when the U.S. Centers for Disease Control published its now famous report describing the death of five gay men in Los Angeles from a rare form of pneumonia. The lethal new virus that terrorized the U.S. gay community that summer has since transformed the world, our culture and our lives.   Some 25 million men, women and children have died, 40 million more are now infected and the plague is still expanding and Sub-Saharan Africa accounts for 73% (25.8 Million) of the people living with HIV. Unfortunately, testing and antiretroviral treatment which can make it manageable is lacking in developing countries. In addition, treatment has not been forthcoming fast enough.   But we can help scale up prevention interventions and arrest the plague. To do our part help combat this plague as it enters its 25th year, A Global Healthcare Public Foundation (www.aglobalhf.org) and Jazz for Peace (www.jazzforpeace.org) will have a special benefit concert on Friday August 4, 2006 from 5 PM to 9 PM at Cada Vez (www.cadavezonline.com) at 1438 U Street, N.W. Washington D.C. The purpose of this event is simple: to create community awareness about this disease and The Foundation’s work, and to raise money in support of The Foundation’s mission to helping rural Sub-Saharan African communities scale up prevention interventions and create strategic partnerships to respond to the AIDS epidemic.  With your help WE have the power to make this cause a success!   Here is how you can help.  To jump start this event and thereby raise immediate funds, Jazz for Peace has been kind enough to offer a limited amount of discount tickets. I ask that you consider supporting this event by purchasing (or sponsoring) a pair (or two pairs) of tickets at $25 each – a $10 ($20) savings! This special discount is available until June 15, 2006, so please send your response for tickets as soon as possible.   Supporting this event not only helps the Foundation, but is a wonderful opportunity to demonstrate your support for the millions of people on the African continent who are directly affected by this disease, as well as a way for friends and family to show their support in a cause close to my heart.   Co-sponsored by the United States Mission to the UN on Sept. 25, 2002, “Jazz for Peace Concert,” featuring renowned Jazz vocalist Rick DellaRatta, has since been recognized worldwide as “one of the single most significant cultural events of our time” and has led to a benefit concert series that raised funds and awareness for over 300 non-profit organizations.   I would like to thank you for your time and look forward to hearing from you! Please call or email me should you like more information. If you do decide to attend, I assure you that you will enjoy yourself!  If you are unable to attend but would like to sponsor somebody, please send your donation to the address below.  Our goal is to raise Five Thousand Dollars!   _____________________________________________________________________________________________

For Immediate release For Immediate Release     March 6, 2006     A Global Healthcare Public Foundation 12209 Bonnet Brim Course Columbia, MD 21044     More than 20 million citizens of sub-Saharan Africa have HIV/AIDS. Sub-Saharan Africa comprises 10% of the world’s population yet they account for more than 60% of the people living with HIV. In 2004 it was estimated that there were 3.1 million new infections and 2.3 million deaths in the continent.   To call attention to this health crisis in Sub-Saharan Africa, the Foundation presents an “HIV/AIDS Documentary” of a trip across West Africa, on April 2, 2006 at Busboys and Poets 2021 14th St NW Washington D.C. in honor of all the women, children and men working hard to combat this epidemic.   The objective of the documentary is to encourage individuals to get educated about HIV/AIDS in Africa, get involved in advocating for recourses needed to fight the disease and get treated should they be living with or newly infected with HIV.   Background: Last year the Foundation, a 501(C)(3) charitable organization, launched its “R U +” (Are You Positive) Campaign to test orphans, street children and rural people for HIV-1/HIV-2 at no cost in West Africa. This initiative was coordinated in four countries, Benin, Cameroon, Nigeria and Togo by local grassroots organizations and tested over 4,000 people for HIV-1 and HIV-2.   For more information please contact us at 1-800 342 4575 or click here

Press release A Global Healthcare Public Foundation Announces 10,000 free HIV Tests June 20, 2005 – Columbia, MD - A Global Healthcare Public Foundation announced today that it will conduct 10,000 free HIV Tests during the week of August 29 to September 3, 2005 in the rural areas of four West African Countries.   The Foundation is a grassroots network consisting of more than 43 volunteers’ communities in Sub-Saharan Africa. Affiliates bolster awareness of the disease and raise funds to support a variety of community-based outreach projects.   Campaign Overview The “R U +” Campaign is intended to carry out free testing of at least 10,000 people for HIV -1/2 (Determine test Kit), to bring awareness to the problem of HIV/AIDS in the rural areas while also allowing the Foundation to inform people, educate them and create awareness about the “ABC” of HIV Prevention. Through programs like “R U +” Campaign and other fundraising and awareness events, the Foundation and affiliates raise thousands of dollars each year to help scale up prevention and fight HIV/AIDS. Last year 84 percent of net income (up from 68% in 2003) remained in the local community to fund educational outreach and medication donations and treatment programs for underserved women, orphans and those without access to healthcare services.   This Campaign is slated to accomplish the following: Provide Free HIV -1/2 Tests to 10,000 people To raise awareness on the plight of HIV/AIDS in the rural areas Identify both negative and positive people in the community To promote collaboration between testing programs and treatment clinics. Additional Information There are many different ways to support the Foundation and the fight to eradicate HIV. You can join us in the search for better prevention and become part of the fight against HIV by making a contribution of $25, $50, $100 or whatever you can afford to support our work at the Foundation. Learn more about donating www.aglobalhf.org .  In order to ensure funds are making the greatest impact, the Foundation works with local medical experts and health centers and community leaders to conduct community needs assessments   There are many opportunities to volunteer; the Foundation needs volunteers to travel to the different countries. All volunteers must be MDs, Nurses, or Allied Health professionals or have a back ground in Public Health.   Questions and Additional Information For more information visit the website; telephone (800) 342 4575 (toll free); or send a message to: info@aglobalhf.org   _________________________________________________________________________________________

View Past Press Releases

February 2005  The Foundation presents 250 pictures taken in Benin, Cameroon, Nigeria and Togo during the it’s recent humanitarian and charity mission. The pictures depict the plight of orphans and vulnerable children, women and girls, poverty and HIV/AIDS in these countries. November 2004 The Foundation, announced that it has reached agreement with Youth Outreach Programme (YOP) an NGO based in Cameroon to represent it within the North West Province. This agreement was immediately followed by the Foundation’s hiring of a full time licensed Nurse to be placed in one of the rural health center of the North West Province. August 2004 AT the XV International AIDS Conference (www.aids2004.org) in Bangkok, Thailand, the Foundation’s President/Founder started discussions with AXIOS (www.axios-group.com) with the aim of scaling up access to medication in two pilot programs in Cameroon and Togo. A documentary of the Foundation’s work thus far was shown (July 15) and well received by delegates to the International AIDS Conference. February 2004  “Brother, we need gloves.” I expected him to ask for microscopes, beds,  injection needles, centrifuges or some testing equipment but all he said was “Brother, we need gloves” stated Mr. Kilian Songwe. December 2003  A Global Healthcare Public Foundation arrived in Cameroon with 70lb boxes of medication for its first medical distribution mission to help subsidies the medication levels in some communities to include two centers in Yaoundé and two in Bamenda. The President /Founder of the Foundation Mr. Kilian Songwe, stated upon arrival that,” This was a great day for public health in Cameroon and a giant leap for the Foundation". __________________________________________________________________________

In the news

Hundreds Throng Anomah Ngu's Clinic The approval of Professor Anomah Ngu's Vanhivax as a therapeutic vaccine by a supervisory committee set by the Minister of Public Health last week has spurred hundreds of HIV/AIDS patients to seek the Professor's salvation. His health unit, Clinique d'Espoir based at the Essos neighbourhood in Yaounde, has within the last four days been over crowded by HIV carriers and patients of various ages. The Professor says he lacks time to rest.  __________________________________________________ When to Start Antiretroviral Therapy? Few topics in HIV medicine evoke as much heated debate as the subject of when to start antiretroviral therapy. The December 1, 2004 issue of Clinical Infectious Diseases provides a relevant research paper and excellent viewpoint articles.   In the first research article, Albert Faye and his team examined the effects of early versus delayed antiretroviral therapy in 83 HIV-infected infants in the French Perinatal cohort. Given the potential for life-long use of combination HIV treatment for HIV-infected infants and children, this group of patients amplifies the concerns about long-term drug toxicities and the interest in strategies that might decrease the total time of drug exposure. Additionally, about one fifth of infected children go on to develop a more severe form of HIV disease (including HIV encephalopathy) and an understanding of prognostic factors for children at risk are lacking. ____________________________________________ CDC Trials of Daily Oral Tenofovir for Preventing HIV Infection New approaches to hiv prevention are urgently needed to stem the estimated five million new hiv infections that occur worldwide each year. While behavior change programs have contributed to dramatic reductions in the number of annual infections in the U.S. and many other nations, far too many individuals remain at high risk. With an effective vaccine years away, there is mounting evidence that antiretroviral drugs may be able to play an important role in reducing HIV infection. As part of its commitment to developing new HIV prevention strategies, the Centers for Disease Control and Prevention (CDC) is sponsoring three clinical trials of the antiretroviral drug tenofovir disoproxil fumarate (or “tenofovir,” brand name “Viread®”). ___________________________________________________________   "Treat 3 million by 2005" (3 by 5) Initiative   "Treat 3 million by 2005" (3 by 5) is the global initiative of the World Health Organization and UNAIDS to provide antiretroviral therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005.   "We must meet the challenge of expanding access to HIV treatment. This requires overcoming the formidable barrier of creating sufficient operational capacity—a key area where UNAIDS Cosponsor WHO must play a critical role. We have adopted a target of 3 million people on antiretroviral treatment by 2005—a massive challenge, but one we cannot afford to miss." - Dr Peter Piot, UNAIDS Executive Director ________________________________________________________________   FDA Public Health Advisory for Nevirapine (Viramune) January 19, 2005 The Food and Drug Administration (FDA) is issuing a public health advisory to inform health care providers and patients about recent safety-related changes to the nevirapine (Viramune) label (package insert) and about appropriate use of HIV triple combination therapy containing nevirapine, which is one treatment option in the United States and which is increasingly being used globally. The nevirapine label has been revised several times over the last two years to include more information on liver toxicity associated with long-term nevirapine use. The Indications and Usage section of the Viramune label now recommends against starting nevirapine treatment in women with CD4+ cell counts greater than 250 cells/mm3 unless benefits clearly outweigh risks. This recommendation is based on a higher observed risk of serious liver toxicity in patients with higher CD4 cell counts prior to initiation of therapy. In addition, the revised label now includes a Medication Guide to inform patients about risks associated with nevirapine when used for the treatment of HIV. Both clinically symptomatic and asymptomatic liver toxicity are observed with long-term use of nevirapine in combination with other HIV drugs. Asymptomatic liver toxicity is defined as increases in liver enzymes without any associated clinical signs or symptoms and is similar to that seen with other antiretroviral drugs. Symptomatic liver toxicity is more common with nevirapine compared to other antiretroviral drugs. Important information regarding symptomatic nevirapine liver toxicity is summarized below: __________________________________________________________________ Have you heard me today? SECRETARY-GENERAL HAILS WOMEN AS MOST COURAGEOUS, CREATIVE CHAMPIONS IN FIGHT AGAINST HIV/AIDS, IN WORLD AIDS DAY MESSAGE MESSAGE ON THE OCCASION OF WORLD AIDS DAY; Dr Peter Piot, Executive Director of UNAIDS and Under Secretary-General of the United Nations Many women and girls are vulnerable to HIV because of the high-risk behavior of others. This year’s World AIDS Campaign, with the strapline ‘Have you heard me today?,’ seeks to raise awareness about, and help address, the many issues affecting women and girls around HIV and AIDS. _________________________________________________________________ Travel away from home linked with risky sex and HIV amongst men in Cameroon Investigators in the Cameroon have found an association between overnight travel from home and being HIV-positive. The study, published in the January 1st edition of the Journal of Acquired Immune Deficiency Syndromes, also found that geographic mobility in men was associated with a higher number of one-off sexual encounters and a greater number of sexual partners. However, investigators failed to find as distinct an association between travel and HIV-status in women. The study confirms that the link between mobility and HIV infection is not confined to rural populations, and that it is a critical feature of urban HIV epidemics too. _________________________________________________________________   AIDS in Africa -- Issue Brief for Congress Sub-Saharan Africa has been far more severely affected by AIDS than any other part of the world. The United Nations reports that 29.4 million adults and children are infected with the HIV virus in the region, which has about 10% of the world’s population but more than 70% of the worldwide total of infected people? The overall rate of infection among adults in sub-Saharan Africa is 8.8%; compared with 1.2% worldwide. Twelve countries, mostly in east and southern Africa, have HIV infection rates of more than 10%, and the rate has reached 38.8% in Botswana. As of 2001, an estimated 21.5 million Africans had died of AIDS, including 2.2 million who died in that year. AIDS has surpassed malaria as the leading cause of death in Africa, and it kills many times more Africans than war. In Africa, HIV is spread primarily by heterosexual contact and 58% of those infected are women.

News People in the News Kilian Songwe: Offers drugs to support Anomah Ngu’s AIDS research Victor Anomah Ngu’s efforts at finding an AIDS cure have won recognition from far and wide. One of those who has recognised his efforts is Kilian Songwe, a Cameroonian health practitioner based in the United States. As concrete support to the Vahnivax discoverer, Kilian who is President/Founder of A Global Healthcare Public Foundation, last Thursday offered a consignment of drugs to help Anomah Ngu relieve the pain of HIV/AIDS patients. The drugs, evaluated at about 4 million FCFA will help cure illnesses like malaria and high blood pressure associated with AIDS. Anomah Ngu is expected to give them to his patients at subsidized prices. A Global Healthcare Public Foundation, INC is focused on reducing healthcare imbalances by partnering with grassroots organisations and clinics to accelerate interventions that will alleviate disease burden. It does this by granting technical and financial assistance, medication and equipment to rural communities in developing countries affected by HIV/AIDS. Kilian says he will concentrate his efforts in Cameroon, Gabon, Togo, Kenya, Senegal, Gambia, Congo Democratic Republic for the time being. He says country governments are free to support their initiative by taking care of the flight ticket of the foundation member bringing in the drugs or equipment.              The Herald Newspaper

Media Coverage